Luminex sees revenue gains in 2013

Feb 4, 2014
Austin Business Journal

Luminex Corp. (Nasdaq: LMNX) saw a slight decline in revenue in the fourth quarter of 2013, but posted a five percent full-year increase in revenue over 2012,  according to an earnings report released by the company on Monday

In the fourth quarter, Luminex saw revenue of $55.2 million, down slightly from the fourth quarter of 2012, with net income of $5.1 million or 12 cents per share. A year earlier, the company had net income of $4.2 million, or 10 cents per share, on revenue of $55.5 million

"Although 2013 was a year marked by unexpected challenges, Luminex responded to these challenges by remaining committed to our strategic programs and long term financial objectives. We have remained focused on accelerating both revenue and earnings growth driven by several key company initiatives in our molecular diagnostics business," said Patrick J. Balthrop, president and chief executive officer of Luminex, in a statement accompanying the report

The company also reported 11 percent increases shipments of its molecular diagnostic equipment

Looking ahead, the company expects 2014 revenue between $225 million and $240 million, a range of 5 to 12 percent higher than 2013

Print Article opens in new window